Therefore, this study generated Msln-CAR T cells modified with CCR2b or CCR4, and findings showed that Msln-CCR2b-CAR and Msln-CCR4-CAR T cells increased migration to tumor supernatants with a high level of Mcp-1 in vitro. The gene discussed is CCR2; the disease is neoplasm.